MTOR and malignant urinary system neoplasm: We found that mTOR rs2295080 TG, GG genotype and GG/TG genotype carriers showed an decreased in the overall cancer risk, urinary system cancer and digestive system cancer, nevertheless TT genotype of rs2295080 was associated with increased the risk of blood system cancer.